Cargando…
Smads as muscle biomarkers in amyotrophic lateral sclerosis
OBJECTIVE: To identify molecular signatures in muscle from patients with amyotrophic lateral sclerosis (ALS) that could provide insight into the disease process and serve as biomarkers. METHODS: RNA sequencing was performed on ALS and control muscle samples to identify Smad family members as potenti...
Autores principales: | Si, Ying, Cui, Xianqin, Kim, Soojin, Wians, Robert, Sorge, Robert, Oh, Shin J, Kwan, Thaddeus, AlSharabati, Mohammad, Lu, Liang, Claussen, Gwen, Anderson, Tina, Yu, Shaohua, Morgan, Dylan, Kazamel, Mohamed, King, Peter H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241805/ https://www.ncbi.nlm.nih.gov/pubmed/25493269 http://dx.doi.org/10.1002/acn3.117 |
Ejemplares similares
Ejemplares similares
-
Transforming Growth Factor Beta (TGF-β) Is a Muscle Biomarker of Disease Progression in ALS and Correlates with Smad Expression
por: Si, Ying, et al.
Publicado: (2015) -
Wnt antagonist FRZB is a muscle biomarker of denervation atrophy in amyotrophic lateral sclerosis
por: Kwan, Thaddaeus, et al.
Publicado: (2020) -
Amyotrophic lateral sclerosis
por: Wijesekera, Lokesh C, et al.
Publicado: (2009) -
Fat mass loss correlates with faster disease progression in amyotrophic lateral sclerosis patients: Exploring the utility of dual-energy x-ray absorptiometry in a prospective study
por: Lee, Ikjae, et al.
Publicado: (2021) -
Longitudinal biomarkers in amyotrophic lateral sclerosis
por: Huang, Fen, et al.
Publicado: (2020)